Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001029142-25-000120
Filing Date
2025-08-25
Accepted
2025-08-25 08:50:44
Documents
1
Period of Report
2025-08-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1756126240.html 4  
1 FORM 4 wk-form4_1756126240.xml 4 3187
  Complete submission text file 0001029142-25-000120.txt   4680
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ZENTALIS PHARMACEUTICALS 10275 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address
Myers Scott Dunseth (Reporting) CIK: 0001356256 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 251248043